JUBILANT PHARMOVA
Back to Cashflow Statement
|
JUBILANT PHARMOVA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,453 Cr | ₹-433 Cr | ₹-157 Cr | ₹-33 Cr | ₹-1,709 Cr |
What is the latest Cash Flow from Financing Activities ratio of JUBILANT PHARMOVA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1,453 Cr |
| Mar2024 | ₹-433 Cr |
| Mar2023 | ₹-157 Cr |
| Mar2022 | ₹-33 Cr |
| Mar2021 | ₹-1,709 Cr |
How is Cash Flow from Financing Activities of JUBILANT PHARMOVA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,453 Cr | Negative | |
| Mar2024 | ₹-433 Cr | Negative | |
| Mar2023 | ₹-157 Cr | Negative | |
| Mar2022 | ₹-33 Cr | Negative | |
| Mar2021 | ₹-1,709 Cr | - | |
Compare Cash Flow from Financing Activities of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹12,885.8 Cr | -2.5% | -13% | -10.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -2.5% |
-13% |
-10.8% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses